Cañendo, Lourdes Y.
HRN: 26-38-18 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2024
CEFTRIAXONE 1G (VIAL)
12/13/2024
12/20/2024
IVTT
2g
Od
Infected Wound
Waiting Final Action
12/23/2024
CEFTRIAXONE 1G (VIAL)
12/23/2024
12/27/2024
IV
2g
Od
Infected Wound
Waiting Final Action